Ludwig Enterprises Announces Publication of ASCO Abstract Detailing Novel Non-Invasive mRNA Signals that Scan for Breast Cancer
Revealia Breast(TM) Offers Glimpse Into the Future of Early Cancer Detection With a Simple Cheek Swab
Ludwig Enterprises Announces Two Abstracts Accepted for Publication in the Journal of Clinical Oncology
Ludwig Enterprises Inc. Announces New Leadership Appointment of Charles T. Todd, Jr.
Ludwig Enterprises Begins PCR Validation Test Process
Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)
CORRECTING AND REPLACING: Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology
Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology
Ludwig Announces Acquisition of Intellectual Property and Patent
Nova Mentis Assigns Intellectual Property
Ludwig Announces Substantial Corporate Initiatives
Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.
